TG Therapeutics Inc (TGTX)
17.08
-0.04
(-0.23%)
USD |
NASDAQ |
May 09, 09:58
TG Therapeutics Market Cap: 2.640B for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 2.646B |
| May 07, 2024 | 2.655B |
| May 06, 2024 | 2.552B |
| May 03, 2024 | 2.502B |
| May 02, 2024 | 2.538B |
| May 01, 2024 | 2.454B |
| April 30, 2024 | 2.111B |
| April 29, 2024 | 2.059B |
| April 26, 2024 | 2.082B |
| April 25, 2024 | 2.150B |
| April 24, 2024 | 2.161B |
| April 23, 2024 | 2.202B |
| April 22, 2024 | 2.179B |
| April 19, 2024 | 2.130B |
| April 18, 2024 | 2.162B |
| April 17, 2024 | 2.136B |
| April 16, 2024 | 2.164B |
| April 15, 2024 | 2.175B |
| April 12, 2024 | 2.189B |
| April 11, 2024 | 2.281B |
| April 10, 2024 | 2.274B |
| April 09, 2024 | 2.334B |
| April 08, 2024 | 2.314B |
| April 05, 2024 | 2.244B |
| April 04, 2024 | 2.235B |
| Date | Value |
|---|---|
| April 03, 2024 | 2.237B |
| April 02, 2024 | 2.232B |
| April 01, 2024 | 2.283B |
| March 28, 2024 | 2.349B |
| March 27, 2024 | 2.404B |
| March 26, 2024 | 2.384B |
| March 25, 2024 | 2.423B |
| March 22, 2024 | 2.392B |
| March 21, 2024 | 2.355B |
| March 20, 2024 | 2.373B |
| March 19, 2024 | 2.367B |
| March 18, 2024 | 2.324B |
| March 15, 2024 | 2.350B |
| March 14, 2024 | 2.372B |
| March 13, 2024 | 2.429B |
| March 12, 2024 | 2.446B |
| March 11, 2024 | 2.528B |
| March 08, 2024 | 2.591B |
| March 07, 2024 | 2.780B |
| March 06, 2024 | 2.815B |
| March 05, 2024 | 2.792B |
| March 04, 2024 | 2.759B |
| March 01, 2024 | 2.773B |
| February 29, 2024 | 2.659B |
| February 28, 2024 | 2.722B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
492.81M
Minimum
Oct 08 2019
7.633B
Maximum
Feb 05 2021
2.537B
Average
2.170B
Median
Market Cap Benchmarks
| Amicus Therapeutics Inc | 2.797B |
| Geron Corp | 2.295B |
| Editas Medicine Inc | 437.70M |
| G1 Therapeutics Inc | 224.29M |
| Mersana Therapeutics Inc | 384.21M |
Market Cap Related Metrics
| PE Ratio | 77.64 |
| PS Ratio | 8.851 |
| Price to Book Value | 16.49 |
| Price to Free Cash Flow | 126.27 |
| Price | 17.08 |
| Earnings Yield | 1.29% |
| Operating PE Ratio | 52.96 |
| Normalized PE Ratio | 77.64 |